Drug · DIN 02466619
BENEFIX
ALSO KNOWN AS NONACOG ALFA
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since July 21, 2017.
- Drug Identification Number (DIN)
- 02466619
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Schedule D
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Coagulation factor ix B02BD04
- Class
- Human
- Record last updated
- August 20, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| COAGULATION FACTOR IX (RECOMBINANT) | 1500 UNIT | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 21, 2017: NOC 19566Supplement to a New Drug Submission (SNDS) · New strength
Other DINs named BENEFIX
- DIN 02293773 · Marketed
- DIN 02293781 · Marketed
- DIN 02293803 · Marketed
- DIN 02392984 · Marketed
- DIN 02293765 · Dormant